Several studies have also reviewed in the two previous reviews [11, 12] and have indicated that the tissue and serum levels of LCN2 are associated with the severity of cancer, recurrence, and poor prognosis in patients, and this may be due to the role of this protein in trafficking iron into the cells. This evidence concerns the gene LCN2 and cancer.